MGN-3

MGN-3

A commercial rice-bran extract which was claimed to be effective in treating cancer and HIV. The FDA concluded that MGN-3 was ineffective, and forbade the purveyors from making further claims of efficacy.
References in periodicals archive ?
TO: ALL PERSONS (ULTIMATE CONSUMERS) WHO PURCHASED BENEFIN, MGN-3, AND/OR SKINANSWER AT ANY TIME BETWEEN SEPTEMBER 22, 1999 AND JULY 12, 2004.
marketed its products BeneFin, MGN-3, and SkinAnswer as treatments for cancer, HIV, and skin cancer without FDA approval.
The claim form will ask you to state how much you spent for BeneFin, MGN-3, and/or SkinAnswer, including both the purchase price and any shipping and handling costs.